Trinity Biotech (TRIB) Cash from Operations (QoQ) (2009 - 2024)
Trinity Biotech (TRIB) Cash from Operations (QoQ) (2009 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn |
| 10 | Trinity Biotech | 6.46 Mn | 1.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -117,948.93% |
| Mar 31, 2024 | -101.07% |
| Dec 31, 2023 | 106.12% |
| Sep 30, 2023 | 28.92% |
| Jun 30, 2023 | -112,964.16% |
| Mar 31, 2023 | -100.28% |
| Dec 31, 2022 | 236.82% |
| Sep 30, 2022 | 34,992.09% |
| Jun 30, 2022 | 99.85% |
| Mar 31, 2022 | -133.30% |
| Dec 31, 2021 | 770.82% |
| Sep 30, 2021 | 37,007.44% |
| Jun 30, 2021 | -99.98% |
| Mar 31, 2021 | -60.30% |
| Dec 31, 2020 | 106.97% |
| Sep 30, 2020 | 157.76% |
| Jun 30, 2020 | 159.76% |
| Mar 31, 2020 | -55.04% |
| Dec 31, 2019 | -50.53% |
| Sep 30, 2019 | 215.53% |